Table 7 Normality of distributions—days to action × medication subtypes
Distribution | M (SD, 95% CI) | Shapiro–Wilk tests of normality | ||
|---|---|---|---|---|
Statistic | df | Significance | ||
Days to action × Anti-epileptics | 5.000 (2.302, 3.952–6.047) | .916 | 21 | 0.071 |
Days to action × Anti-parkinsonians | 3.667 (2.065, 1.499–5.834) | .917 | 6 | 0.487 |
Days to action × Anti-psychotics | 4.637 (2.331, 4.183–5.091) | .938 | 102 | < 0.001 |
Days to action × Anxiolytics | 3.800 (2.050, 3.217–4.824) | .849 | 50 | < 0.001 |
Days to action × Sedatives | 3.000 (2.121, 0.336–5.634) | .899 | 5 | 0.405 |
Days to action × Anti-depressants | 4.369 (2.382, 3.956–4.783) | .932 | 130 | < 0.001 |
Days to action × Psychostimulants | 5.833 (2.125, 4.483–7.183) | .971 | 12 | 0.918 |
Days to action × Nervous system drugs | 4.200 (2.683, 0.868–7.532) | .838 | 5 | 0.160 |